DONATE

Cell culture lab technician at the Bioengineering in Reproductive Health Research Group


Application Deadline: 30/06/2020
Ref: LT-SO

The Bioengineering in Reproductive Health Group offers a lab technician position for an experienced cell culture technician to develop a project in collaboration with the industry. The project involves testing the effects of different cell culture supplements on several cell types (e.g. Mesenchymal Stromal Cells, CAR T Cells, etc.)

Our laboratory is a multidisciplinary environment where biologists, biophysicists, clinicians and business developers synergize to create a unique environment shaped by science and entrepreneurship. Due to the high translational component of our research, we have established collaboration contracts with the pharma industry, hospitals and venture capital to bring our technology to the clinics and the market.

In our lab, we develop high-tech projects in the fields of embryology, cell biology and imaging. Our strategy involves the development of new products for the pharmaceutical industry. The current position seeks a motivated cell culture technician with experience in diverse cell culture systems.

Magnet Alliance on the radio

Àngels Suarez, teacher at Gayarre school, explained the alliance between IBEC and the Gayarre School within the frame of the project “Magnet, alliances for educational success”. This initiative unites educational centres that have an unbalanced social composition with an institution of excellence for 4 years. This union will allow the educational centre to develop an innovative project that will become a reference project in its territory. During her intervention, she also shared with the audience a virtual experiment, easy to perform in our homes, to explain the density.

IBEC receives a visit from the Mayor of Barcelona interested in our research against Covid19

The Mayor of Barcelona, Ada Colau, visited IBEC facilities last Friday to learn, by our Director and a group of researchers, how bioengineering can help find solutions to health problems such as COVID19, cancer, or degenerative diseases.

When in early 2020, more than 200 scientists gathered in La Pedrera in Barcelona to discuss the present and future of bioengineering, no one imagined that the world would experience the first pandemic of the 21st century and that science would take on more importance than ever.

IBEC researchers find a new way to effectively transport drugs to the brain

An international group of researchers from the University of Maryland (United States) and the Institute for Bioengineering of Catalonia (IBEC) led by ICREA Research Professor Silvia Muro, has identified a new way of transporting drugs to the brain, one of the major challenges of the pharmaceutical science today, that could help to come up with new treatments for neurological diseases such as Parkinson’s or Alzheimer’s.

To find this out, the experts linked an antibody capable of recognizing the ICAM-1 protein -a molecule expressed on the surface of blood vessels- to a series of polymeric nanoparticles that can transport drugs and inject them intravenously.

Head of Tech Transfer and Business Development Office

Application Deadline: 30/06/2020
Ref: TTO_DB
IBEC seeks a Head of Tech Transfer and Business Development. The successful candidate will be responsible for designing, developing and executing an overall strategy to scout new discoveries and results in the institute, support IBEC’s scientists during technology valorization and intellectual property development, and commercialize those results to ensure beneficial impact on society.

The office will support the IBEC technology and business development capacity and will boost communication between IBEC community and external stakeholders in the innovation arena.

The Head of Tech Transfer and Business Development Office runs a team of 2 people and reports to the Managing Director and is part of the Institute’s senior management team.

Research centres in Catalonia have conducted 20,000 PCR tests to date

The Center for Genomic Regulation (CRG), the National Center for Genomic Analysis (CNAG-CRG), part of CRG, the Institute for Research in Biomedicine (IRB Barcelona) and the Institute for Bioengineering of Catalonia (IBEC) have analysed more than 20,000 samples to date using the PCR technique. In this regard, 17,547 samples have been tested at the CRG node and 5,248 at the PCB node.

The analyses are part of the Orfeu Programme, the mass screening initiative driven by the Government of Catalonia. As of today, the public health system in Catalonia can carry out up to 17,000 PCR tests every day. This number does not include the capacity of the Orfeu Programme, which can process up to 4,000 samples per day.

Practicant Web a la Unitat de Comunicació i Divulgació

Application Deadline: 11/06/2020
Ref: COM_GO
L’Institut de Bioenginyeria de Catalunya (IBEC) requereix incorporar un/-a estudiant en pràctiques a la unitat de Comunicació i Divulgació de l’IBEC per donar suport en l’àmbit de l’entorn web.

IBEC receives funding from Carlos III Health Institute to fight COVID-19 using bioengineering

The COVID-19 Fund managed by the Carlos III Health Institute has awarded more than 300,000 euros to the “ACE2-ORG” project led by ICREA research professor Núria Montserrat at IBEC.

The resources are intended to study COVID-19 and specify new therapeutic approaches against the SARS-CoV-2 coronavirus, the Karolinska Institute in Sweden, the Institute of Molecular Biotechnology of the Austrian Academy of Sciences, the Hospital Clínic de Barcelona and the University of Navarra also participate in this project.

IBEC supports the EU initiative “Coronavirus Global Response”

The Institute for Bioengineering of Catalonia (IBEC) supports the EU initiative to pledge funds for collaborative development of solutions against COVID19. Carmen Hurtado, from the Group of ICREA Professor Núria Montserrat at IBEC contributes to spread the word of “Coronavirus Global Response” initiative in a video for the European Commission.

The European Union and its partners are hosting an international pledging marathon that started last Monday 4 May 2020 and will be running until the end of May 2020.